Dr. Rajiv Ranjan is a CXO Coach, Veteran Strategist, Constituted Attorney, Corporate US Patent Practitioner and Advance Patent Agent, Veteran Computer Scientist, Serial Disruptive Innovator, Domain-Agnostic Subject Matter Expert (SME) and had/has been a strategic adviser to various corporate and academic institutions including MNCs, like Schneider Electric, mySkin-Partly Invested by Evonik, Altran, PowerSquare, Silabtech (now Silicon&Beyond)-Acquired by Synopsys, Pangea3-Acquired by Thompson Reuters, Inventurus-A Captive Cost Center of Haynes & Boone, LLP, Standard & Poor’s (S&P’s) Corporate Value Consulting - McGraw-Hill, India Accelerator, WNS Global, etc. in various areas including high-end technologies, marketing, finance, law and IP. Besides, Rajiv is also advisor to international investors and board of directors of various companies and also an advanced technology, innovation and investment intermediary.
Dr. Rajiv directly advised CXO-level authorities and dignitaries in various corporate and academic institutions, namely Co-Head European Collateralized Loan & Debt Obligation (CLO & CDO) Structuring - JP Morgan, Vice President - CLO & CDO Structuring - Credit Suisse First Boston, Chief Quantitative Analyst - Merrill Lynch; CEOs & COOs from Harvard Business School; Kashif Saleem nominated for Ernst & Young Entrepreneur of the Year, Curtin Entrepreneur of the Year, Innovator of the Year 40 under 40, David Perla, Founder of Monster India, etc.
Dr. Rajiv has worked in close coordination with Daniel Y. J. Kim, US Patent Attorney, J.D., Electrical Eng., Cornell University J.D., Washington College of Law, The American University; Hazim Ansari, US Patent Attorney, Electrical Eng., Stanford University; Olli Rahnasto ranked among top 100 ATP players in the world and Ex-Captain of Finland Davis Cup team; Trade Commissioner - Association of Southeast Asian Nations (ASEAN) & Consulate General of Maldives in India.
Dr. Rajiv was handpicked/nominated by Late Prof. Dr. T. Vishwanathan, Ex-Director General of Council of Scientific and Industrial Research (CSIR), Serial Author - Theory of Boolean Switching, PHI, and Chairperson European Organization for Nuclear Research (or Conseil européen pour la recherche nucléaire) (CERN), Geneva and delivered sessions on Compiler Design/Automata Language Control/Parallel Computing/Theory of Boolean Switching for, or on behalf of, the Ex-Director General of CSIR as well as mentored Senior Management Team from World Bank in Sri Lanka.
Dr. Rajiv in the past has served as IPR & R&D Advisor to Acacia Research Corporation, Silabtech-Synopsys, Indian National Scientific Documentation Center (INSDOC), now National Institute of Science Communication and Information Resources (NISCAIR), a Council of Scientific and Industrial Research (CSIR) Lab of Government of India, South Asian Association for Regional Cooperation (SAARC) Documentation Center (SDC), Associateship In Information Science (AIS)-CSIR, Track’Em AU, Schneider Electric, mySkin-Partly Invested by Evonik, Altran, PowerSquare, Motorola Laboratory, and many more.
Dr. Rajiv has solo- or co-ideated, co-invented, drafted, filed, prosecuted, asserted and enforced more than 3000 advanced and complex technology patent applications. He is a multi-skilled professional with extensive knowledge in Technology, Patents, Trademarks, Investments, Licensing, Strategy and Branding. He is world class expert in various technologies including IoT, Blockchain, Quantum Positioning, Quantum Cryptography, Quantum Computing, Cloud Computing, Robotics, Cryptocurrency, SAAS, SOA, NB-IoT, LORA, Bio-Signal Processing, Biomechanics, Biophysics and others. He is positioned among top 1% profile on LinkedIn and well connected with and professionally advised CEOs/CTOs of various MNCs, scientists, bureaucrats, and investors.
Dr. Rajiv have had the opportunity to serve world’s largest EPC contractor Caltech based in UK in connection with techno-legal and techno-market work. Dr. Rajiv has also drafted/developed patent applications for Nvidia Germany. He has also drafted/developed patents for Intel for multiprocessor QUAD architecture. In addition, he has drafted/developed patents for Adobe, Sony, LG, Symantec - Veritas, Cubic Defense Systems (Gemalto), Applied Materials, Dolphin Medical, Newport Corporation, Yahoo - Verdisoft, Rapiscan, Raytheon, OSI Fibercom - UDT Sensors and several other small, mid and large size firms. He has also represented our client [pro se legal representation and as Constituted Attorney] against Merchant and Gould, P.C. in a trademark opposition case in TTAB for, or on behalf of, mySkin, Inc.
Dr. Rajiv recently has gotten high-value patents and trademarks/service marks granted for mySkin, Inc., PowerSquare Inc., Zestle, Twinvaves Technologies Private Limited, mySkin, d.o.o., Sicontech, Silabtech, Track’Em and many more. He has in the past enforced our client’s brands “mySkin” against North Eastern University, Skin & Cancer Foundation, Inc., UrbanOrca and “PowerSquare” against Jack Dorsey’s Square, Inc. He recently was successful in getting the decision of Examiner reversed in a hearing before an esteemed panel of administrative judges of the PTAB, USPTO in a long-standing pending complex patent matter of mySkin, Inc. He was also recently invited as an advisory member of a 12-member advisory panel for drafting/development of AI Policy Framework for the United States USPTO.
Dr. Rajiv has received invitation as a guest on The Big-Ticket Clients Show hosted by Dr. Pele, Bestselling Author and Host of The Big-Ticket Clients Podcast™ for an interview and debate.
De Incubator discloses a proprietary technology and business incubation model captioned “Disruptive Incubation-As-A-Service (DIAAS)”, which model facilitates in collaboratively ideating, brainstorming, idea networking, prototyping, patenting, productizing, commercializing, by way of enforcing - licensing, transferring and selling IP and technologies, as well as investing when subjected to implementation both in the context of academia and corporate. DIAAS, inter alia, comprises implementation of multiple hard and soft tools facilitating Advanced Strategic & Applied IP Asset Management (ASAIPAM), Strategic Lean Patent Development Life Cycle (PDLC), Strategic Lean Patent-Information Guided Product/Solution Development Life Cycle (PSDLC) and Structured Object-Oriented Natural Language-Based Patent Programming & Development. DIAAS may facilitate strategically positioning startups/SMEs on global IP & Innovation map as well as in building, operating and managing an investor-ready portfolio of captive startups/SMEs, as well as corresponding IP assets therefor.
De Incubator’s "Disruptive Incubation-As-A-Service" technology/business/academic incubation model facilitates Start-ups/SMEs rite from inception, incorporation to final graduation. We specialize in bridging gaps/whitespaces/loopholes between academia and corporate as well as growth hacking plus go-to market strategy via facilitating collaborative ideation, brainstorming, idea networking, rapid prototyping, patenting, productizing and transferring/licensing technology and IP. We solidly understand the value of intangible IP assets from the standpoint of Positive Return-on-Patents (or IP) and monetization of such IP assets. We facilitate building, operating, transferring, licensing and monetizing marketable and saleable IP assets.